55 related articles for article (PubMed ID: 11726827)
1. Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: analysis of incidence and risk factors.
Maes BD; Kuypers D; Messiaen T; Evenepoel P; Mathieu C; Coosemans W; Pirenne J; Vanrenterghem YF
Transplantation; 2001 Nov; 72(10):1655-61. PubMed ID: 11726827
[TBL] [Abstract][Full Text] [Related]
2. Adverse effects associated with the use of FK 506.
Fung JJ; Alessiani M; Abu-Elmagd K; Todo S; Shapiro R; Tzakis A; Van Thiel D; Armitage J; Jain A; McCauley J
Transplant Proc; 1991 Dec; 23(6):3105-8. PubMed ID: 1721372
[No Abstract] [Full Text] [Related]
3. The use of FK 506 in new-onset type I diabetes in man.
Carroll PB; Tzakis AG; Ricordi C; Rilo HR; Abu-Elmagd K; Murase N; Zeng YJ; Alejandro R; Mintz D; Starzl TE
Transplant Proc; 1991 Dec; 23(6):3351-3. PubMed ID: 1721458
[No Abstract] [Full Text] [Related]
4. Diabetes mellitus after kidney transplantation in the United States.
Kasiske BL; Snyder JJ; Gilbertson D; Matas AJ
Am J Transplant; 2003 Feb; 3(2):178-85. PubMed ID: 12603213
[TBL] [Abstract][Full Text] [Related]
5. New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003.
Davidson J; Wilkinson A; Dantal J; Dotta F; Haller H; Hernández D; Kasiske BL; Kiberd B; Krentz A; Legendre C; Marchetti P; Markell M; van der Woude FJ; Wheeler DC;
Transplantation; 2003 May; 75(10 Suppl):SS3-24. PubMed ID: 12775942
[No Abstract] [Full Text] [Related]
6. Diabetic Kidney Disease in Post-Transplant Diabetes Mellitus: Causes, Treatment and Outcomes.
Lim LM; Chang JM; Kuo HT
Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831005
[TBL] [Abstract][Full Text] [Related]
7. The effect of tacrolimus-induced toxicity on metabolic profiling in target tissues of mice.
Xie D; Guo J; Dang R; Li Y; Si Q; Han W; Wang S; Wei N; Meng J; Wu L
BMC Pharmacol Toxicol; 2022 Nov; 23(1):87. PubMed ID: 36443830
[TBL] [Abstract][Full Text] [Related]
8. New Onset of Diabetes Mellitus and Associated Factors among COVID-19 Patients in COVID-19 Care Centers, Addis Ababa, Ethiopia 2022.
Sane AH; Mekonnen MS; Tsegaw MG; Zewde WC; Mesfin EG; Beyene HA; Ashine TM; Tiruneh KG; Mengistie MA
J Diabetes Res; 2022; 2022():9652940. PubMed ID: 36420090
[TBL] [Abstract][Full Text] [Related]
9. Analysis of risk factors and establishment of a risk prediction model for post-transplant diabetes mellitus after kidney transplantation.
Cheng F; Li Q; Wang J; Wang Z; Zeng F; Zhang Y
Saudi Pharm J; 2022 Aug; 30(8):1088-1094. PubMed ID: 36164572
[TBL] [Abstract][Full Text] [Related]
10. New Onset Diabetes Mellitus after Transplant: The Challenge Continues.
Aziz F
Kidney360; 2021 Aug; 2(8):1212-1214. PubMed ID: 35369659
[No Abstract] [Full Text] [Related]
11. Diabetes mellitus in dialysis and renal transplantation.
Ben-David E; Hull R; Banerjee D
Ther Adv Endocrinol Metab; 2021; 12():20420188211048663. PubMed ID: 34631007
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and Risk Factors of New-Onset Diabetes After Transplantation (NODAT).
Zielińska K; Kukulski L; Wróbel M; Przybyłowski P; Zakliczyński M; Strojek K
Ann Transplant; 2020 Aug; 25():e926556. PubMed ID: 32839423
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for new-onset diabetes mellitus after kidney transplantation: A systematic review and meta-analysis.
Xia M; Yang H; Tong X; Xie H; Cui F; Shuang W
J Diabetes Investig; 2021 Jan; 12(1):109-122. PubMed ID: 32506801
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and Predictors of "New-onset Diabetes after Transplantation" (NODAT) in Renal Transplant Recipients: An Observational Study.
Choudhury PS; Mukhopadhyay P; Roychowdhary A; Chowdhury S; Ghosh S
Indian J Endocrinol Metab; 2019; 23(3):273-277. PubMed ID: 31641626
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Angiotensinogen M235T and T174M Polymorphisms, Demographic and Clinical Factors in New-Onset Diabetes after Liver Transplantation in Iranian Patients.
Mottaghi S; Azarpira N; Dehshahri A; Khalvati B; Namazi S
Int J Organ Transplant Med; 2019; 10(3):137-147. PubMed ID: 31497276
[TBL] [Abstract][Full Text] [Related]
16. Effect of CYP3A5 genotype on hospitalization cost for kidney transplantation.
Vannaprasaht S; Limwattananon C; Anutrakulchai S; Chan-On C
Int J Clin Pharm; 2019 Feb; 41(1):88-95. PubMed ID: 30446894
[TBL] [Abstract][Full Text] [Related]
17. ISPAD Clinical Practice Consensus Guidelines 2018: Definition, epidemiology, and classification of diabetes in children and adolescents.
Mayer-Davis EJ; Kahkoska AR; Jefferies C; Dabelea D; Balde N; Gong CX; Aschner P; Craig ME
Pediatr Diabetes; 2018 Oct; 19 Suppl 27(Suppl 27):7-19. PubMed ID: 30226024
[No Abstract] [Full Text] [Related]
18. Serum Magnesium after Kidney Transplantation: A Systematic Review.
Garnier AS; Duveau A; Planchais M; Subra JF; Sayegh J; Augusto JF
Nutrients; 2018 Jun; 10(6):. PubMed ID: 29882768
[TBL] [Abstract][Full Text] [Related]
19. Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes.
Shivaswamy V; Boerner B; Larsen J
Endocr Rev; 2016 Feb; 37(1):37-61. PubMed ID: 26650437
[TBL] [Abstract][Full Text] [Related]
20. CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation.
Quteineh L; Bochud PY; Golshayan D; Crettol S; Venetz JP; Manuel O; Kutalik Z; Treyer A; Lehmann R; Mueller NJ; Binet I; van Delden C; Steiger J; Mohacsi P; Dufour JF; Soccal PM; Pascual M; Eap CB;
Pharmacogenomics J; 2017 Jan; 17(1):69-75. PubMed ID: 26644205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
